Mohs micrographic surgery, sentinel lymph node mapping, and estrogen receptor analysis for the treatment of malignant nodular hidradenoma

Dermatologic Surgery

Volumn 32, Issue 10, 2006, Pages 1294-1301

  Tolland, Julia P ^a   Brenn, Thomas ^b   Guldbakke, Kjetil K ^b   Schanbacher, Carl F ^b,c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; PANCYTOKERATIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CELL NUCLEUS; CELL ULTRASTRUCTURE; CHEMOSURGERY; CLINICAL FEATURE; CYTOARCHITECTURE; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MALIGNANT NODULAR HIDRADENOMA; PAIN; PATIENT REFERRAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SWEAT GLAND CARCINOMA; SYMPTOM; TUMOR BIOPSY;

ADENOMA, SWEAT GLAND; AGED; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; FOOT; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOHS SURGERY; RECEPTORS, ESTROGEN; SENTINEL LYMPH NODE BIOPSY; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750002618     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32295.x     Document Type: Article

References (46)

1. Wick MR, Goellner JR, Wolfe JT, et al. Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer 1985;56:1147-62.
2. Levene MB, Haynes HA, Goldwyn RM. Cancers of the skin. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: J.B. Lippincott, 1982:p. 1094-123.
3. Hernandez-Perez E, Cestoni-Porducci R. Nodular hidradenoma and hidradenocarcinoma: a 10-year review. J Am Acad Dermatol 1985;12:15-20.
4. Dissanayake RV, Salm R. Sweat gland carcinomas: prognosis related to histological type. Histopathology 1980;4:445-66.
5. Wertkin MG, Bauer JJ. Sweat gland carcinomas: current concepts of surgical management. Arch Surg 1976;111:884-5.
6. Wildemore JK, Lee JB, Humphreys TR. Mohs surgery for malignant eccrine neoplasms. Dermatol Surg 2004;30:1574-9.
7. Bogner PN, Fullen DR, Loew L, et al. Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer 2003;97:2285-9.
8. Delgado R, Kraus D, Coit DG, et al. Sentinel lymph node analysis in patients with sweat gland carcinoma. Cancer 2003;97:2279-84.
9. Schroder U, Dries V, Wittekindt C, et al. Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: need for a clinical trial? Ann Otol Rhinol Laryngol 2004;113:242-4.
10. Swanson PE, Cherwitz DL, Neumann MP, et al. Eccrine sweat gland carcinoma: an histologic and immunohistochemical study of 32 cases. J Cutan Pathol 1987;14:65-86.
11. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma: a clinicopathologic study of 35 cases. Arch Dermatol 1983;119:104-14.
12. Johnson BL, Helwig EB. Eccrine acrospiroma: a clinicopathologic study. Cancer 1969;23:641-57.
13. Mambo NC. Eccrine spiradenoma. clinical and pathology study of 49 tumours. J Cutan Pathol 1983;10:312-20.
14. Ashley I, Smith-Reed M, Chernys A. Sweat gland carcinoma: case report and review of the literature. Dermatol Surg 1997;23:129-33.
15. Ohta M, Hiramoto M, Fujii M, et al. Nodular hidradenocarcinoma on the scalp of a young woman: case report and review of literature. Dermatol Surg 2004;30:1265-8.
16. Lopez-Burbano LF, Cimorra GA, Gonzalez-Peirona E, et al. Malignant clear-cell hidradenoma. Plast Reconstr Surg 1987;80:300-3.
17. Watanabe S, Ichikawa E, Takanashi S, et al. Immunohistochemical localization of cytokeratins in normal eccrine glands, with monoclonal antibodies in routinely processed, formalin-fixed, paraffin-embedded sections. J Am Acad Dermatol 1993;28:203-12.
18. Wallace ML, Smoller BR. Immunohistochemistry in diagnostic dermatology. J Am Acad Dermatol 1996;34:163-83.
19. Headington JT, Niederhuber JE, Beals TF. Malignant clear cell acrospiroma. Cancer 1978;41:641-7.
20. Cooper PH. Mitotic figures in sweat gland adenomas. J Cutan Pathol 1987;14:10-4.
21. Waxtein L, Vega E, Cortes R, et al. Malignant nodular hidradenoma. Int J Dermatol 1998;37:225-8.
22. Wu H, Elenitsas R. Malignant nodular hidradenoma in a patient with neurofibromatosis type 1: a case report and review of the literature. Cutis 2001;68:273-8.
23. Park HJ, Kim YC, Cinn YW. Nodular hidradenocarcinoma with prominent squamous differentiation: case report and immunohistochemical study. J Cutan Pathol 2000;27:423-7.
24. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999;12:786-93.
25. Sheniker T, Weir L, Levine M, et al. Clinical practice guidelines for the care and treatment of breast cancer: treatment for women with stage III or locally advanced breast cancer. CMAJ 2004;170:983-94.
26. Mirza I, Kloss R, Sieber SC. Malignant eccrine spiradenoma. Arch Pathol Lab Med 2002;126:591-4.
27. Daniel SJ, Nader R, Kost K, et al. Facial sweat gland carcinoma metastasizing to neck nodes: a diagnostic and therapeutic challenge. Arch Otolaryngol Head Neck Surg 2001;127:1495-8.
28. Harvey JM, Clark GM, Osborne K, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
29. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: a controversy despite widespread agreement. J Clin Oncol 2001;19:2851-5.
30. Eedy DJ. Introducing controversies in dermatology: sentinel lymph node biopsy for cutaneous melanoma - a useful technique or a waste of time? Br J Dermatol 2004;151:267-8.
31. Losee JE, Markowitch W Jr, Reale VF. Sweat gland carcinoma of the foot: a review and patient report. Ann Plast Surg 1988;41:550-4.
32. Chang AS, Busam MD, Kraus DK. Applicability of lymphoscintigraphy with sentinel node biopsy to eccrine carcinoma of the head and neck. Head Neck 2003;25:879-82.
33. Harari PM, Shimm DS, Bangert JL, et al. The role of radiotherapy in the treatment of malignant sweat gland neoplasms. Cancer 1990;65:1737-40.
34. Lim SC, Lee MJ, Kee KH, et al. Giant hidradenocarcinoma: a report of malignant transformation from nodular hidradenoma. Pathol Int 1998;48:818-23.
35. Briddlestone LR, Mclaren KM, Tidman MJ. Malignant hidradenoma - a case report demonstrating insidious histological and clinical progression. Clin Exp Dermatol 1991;16:474-7.
36. Holden B, Colome-Grimmer M, Savage C, et al. Malignant eccrine acrospiroma with metastasis to the parotid. Ear Nose Throat J 2002;81:352-5.
37. Dzubow LM, Grossman DJ, Johnson B. Eccrine adenocarcinoma - report of a case, treatment with Mohs surgery. J Dermatol Surg Oncol 1986;12:1049-53.
38. Tay JS, Tapen EM, Solari PG. Malignant eccrine spiradenoma: case report and review of the literature. Am J Clin Oncol 1997;20:552-7.
39. Messing MJ, Richardson MS, Smith MT, et al. Metastatic clear-cell hidradenocarcinoma of the vulva. Gynecol Oncol 1993;48:264-8.
40. Massad LS, Bitterman P, Clarke-Pearson DL. Metastatic clear cell eccrine hidradenocarcinoma of the vulva: survival after primary surgical resection. Gynecol Oncol 1996;61:287-90.
41. Gortler I, Koppl H, Stark GB, Horch RE. Metastatic malignant acrospiroma of the hand. Eur J Surg Oncol 2001;27:431-5.
42. Dave VK. Eccrine sweat gland carcinoma with metastases. Br J Dermatol 1972;86:95-7.
43. Okada N, Ota J, Sato K, Kitano Y. Metastasizing eccrine sweat gland carcinoma: report of a case. Arch Dermatol 1984;120:768-9.
44. Khalil HM, Yusuf H, Kaddour HS. Malignant eccrine hidradenoma of neck causing acute heart failure. Auris Nasus Larynx 2003;30:307-10.
45. Wong TY, Suster S, Nogita T, et al. Clear cell eccrine carcinomas of the skin: a clinicopathologic study of nine patients. Cancer 1994;73:1631-43.
46. Wilson KM, Jubert AV, Joseph JI. Sweat gland carcinoma of the hand (malignant acrospiroma). J Hand Surg [Am] 1989;14:531-5.